Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination by Pejoski, D, de Rham, C, Martinez-Murillo, P, Santoro, F, Auderset, F, Medaglini, D, Pozzi, G, Vono, M, Lambert, P-H, Huttner, A, Haks, MC, Ottenhoff, THM, Villard, J, Siegrist, C-A, VEBCON Consortium, VSV-EBOVAC Consortium, VSV-EBOPLUS Consortium

Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study by Vianello, E, Gonzalez-Dias, P, van Veen, S, Engele, CG, Quinten, E, Monath, TP, Medaglini, D, Agnandij, ST, Ahmed, R, Anderson, J, Auderset, F, Bejon, P, Borgianni, L, Brosnahan, J, Ciabattini, A, Engler, O, Haks, MC, Harandi, AM, Heppner, DG, Gerlini, A, Huttner, A, Kremsner, PG, Ndungu, FM, Njuguna, P, Ottenhoff, THM, Pejoski, D, Page, M, Pozzi, G, Santoro, F, Siegrist, CA, Dubey, S, Eichberg, M, Ndong, EP, Lumeka, K, Nakaya, HI, Gonzales Dias Carvalho, P, Rothenberger, S, Nakka, SS, Essone, PN, Agnandji, ST